Full Press Release Details
BridgeBio Pharma, Inc. Reports First Quarter 2022 Financial Results And Business Update.
BBIO
BridgeBio Pharma, Inc. Reports First Quarter 2022 Financial Results And Business Update
Key Takeaway: BridgeBio Pharma, Inc. Reports First Quarter 2022 Financial Results And Business Update
Price reaction · baseline $5.66 (2022-05-09 close) · hit after-hours · 2 other BBIO headline(s) in the window, move may be shared
day 0 close
+6.9%
day 1
-8%
day 3 · peak
+17%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+41%
120-day peak, hindsight
Typical move
3.6%
average across 13 past catalysts
Cash runway
~30 mo
Minimal dilution risk
Lead asset
acoramidis
Phase 3 · Amyloidosis